Brief: TOT Biopharm International Says FY Loss Attributable RMB288.5 Mln
23/03/2021 15:05
March 23 (Reuters) - TOT BIOPHARM International Co Ltd
1875.HK :
* FY REVENUE RMB22.5 MILLION VERSUS RMB45.3 MILLION
* LOSS FOR YEAR ATTRIBUTABLE RMB288.5 MILLION VERSUS LOSS
RMB299.3
MILLION
Source text https://www1.hkexnews.hk/listedco/listconews/sehk/2021/0323/2021032301689.pdf
Further company coverage: 1875.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioDlink International
See all newsCorrected: China's BioDlink International HY revenue falls (September 29)
Brief: Biodlink International To Deliver Ten Batches Of Monoclonal Antibody Intermediates To Wuxi Biologics
Brief: Biodlink International Says Shan Fu Resigns As Executive Director And Chairperson
Brief: BioDlink International Says WuXi XDC Cayman To Make Conditional Cash Offer For All Co Shares
Brief: HKEX Says Trading In Shares Of Biodlink International Will Be Halted At Dec 29